Chaoju Eye Care Holdings Limited (HKG:2219)

Market Cap	2.00B +7.1%
Revenue (ttm)	1.51B -3.2%
Net Income	204.14M -6.0%
EPS	0.29 -7.1%
Shares Out	693.30M
PE Ratio	9.95
Forward PE	8.38
Dividend	0.24 (8.68%)
Ex-Dividend Date	May 14, 2026

Volume	2,153,000
Average Volume	639,386
Open	2.790
Previous Close	2.790
Day's Range	2.790 - 3.040
52-Week Range	2.440 - 3.130
Beta	0.49
RSI	63.61
Earnings Date	Mar 31, 2026

About Chaoju Eye Care Holdings

Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, myopia prevention and control, dry eye syndrome, and oculoplastic, as well as optical products and services. The company also provides treatment for eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, and pediatric eye di...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1988
• Employees: 2,590
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2219

Financial Performance

In 2025, Chaoju Eye Care Holdings's revenue was 1.36 billion, a decrease of -3.21% compared to the previous year's 1.41 billion. Earnings were 183.45 million, a decrease of -5.96%.

Financial numbers in CNY